Xin Zhai - Search Results

Year	Number of Results
2002	2
2006	1
2007	1
2008	4
2009	1
2010	3
2011	7
2012	9
2013	2
2014	3
2015	2
2016	10
2017	7
2018	7
2019	10
2020	14
2021	17
2022	18
2023	9
2024	4

1

An updated patent review of autotaxin inhibitors (2017-present).

Tan Z, Lei H, Guo M, Chen Y, Zhai X. Tan Z, et al. Among authors: zhai x. Expert Opin Ther Pat. 2021 May;31(5):421-434. doi: 10.1080/13543776.2021.1867106. Epub 2021 Jan 12. Expert Opin Ther Pat. 2021. PMID: 33342311 Review.

2

Nucleoside and Non-Nucleoside DOT1L Inhibitors: Dawn of MLLrearranged Leukemia.

Cao M, Li T, Chen Y, Zhai X. Cao M, et al. Among authors: zhai x. Mini Rev Med Chem. 2021;21(11):1337-1350. doi: 10.2174/1389557521666210111144357. Mini Rev Med Chem. 2021. PMID: 33430727 Review.

3

The physiological functions and pharmaceutical applications of inulin: A review.

Wan X, Guo H, Liang Y, Zhou C, Liu Z, Li K, Niu F, Zhai X, Wang L. Wan X, et al. Among authors: zhai x. Carbohydr Polym. 2020 Oct 15;246:116589. doi: 10.1016/j.carbpol.2020.116589. Epub 2020 Jun 11. Carbohydr Polym. 2020. PMID: 32747248 Review.

4

An updated patent review of anaplastic lymphoma kinase inhibitors (2018-2022).

Ma D, Guo M, Zhai X. Ma D, et al. Among authors: zhai x. Expert Opin Ther Pat. 2023 Apr;33(4):323-337. doi: 10.1080/13543776.2023.2216381. Epub 2023 May 23. Expert Opin Ther Pat. 2023. PMID: 37208827 Review.

5

An update on allosteric modulators as a promising strategy targeting histone methyltransferase.

Tan Z, Li T, Lei H, Zhai X. Tan Z, et al. Among authors: zhai x. Pharmacol Res. 2021 Oct;172:105865. doi: 10.1016/j.phrs.2021.105865. Epub 2021 Aug 31. Pharmacol Res. 2021. PMID: 34474102 Review.

6

Resilience Training for Nurses: A Meta-analysis.

Zhai X, Ren LN, Liu Y, Liu CJ, Su XG, Feng BE. Zhai X, et al. J Hosp Palliat Nurs. 2021 Dec 1;23(6):544-550. doi: 10.1097/NJH.0000000000000791. J Hosp Palliat Nurs. 2021. PMID: 34313624

7

Approach in Improving Potency and Selectivity of Kinase Inhibitors: Allosteric Kinase Inhibitors.

Wei S, Zhao T, Wang J, Zhai X. Wei S, et al. Among authors: zhai x. Mini Rev Med Chem. 2021;21(8):991-1003. doi: 10.2174/1389557521666201222144355. Mini Rev Med Chem. 2021. PMID: 33355051 Review.

8

Gain-of-function mutations in the catalytic domain of DOT1L promote lung cancer malignant phenotypes via the MAPK/ERK signaling pathway.

Zhang J, Yang T, Han M, Wang X, Yang W, Guo N, Ren Y, Cui W, Li S, Zhao Y, Zhai X, Jia L, Yang J, Wu C, Wang L. Zhang J, et al. Among authors: zhai x. Sci Adv. 2023 Jun 2;9(22):eadc9273. doi: 10.1126/sciadv.adc9273. Epub 2023 May 31. Sci Adv. 2023. PMID: 37256945 Free PMC article.

9

The regulatory mechanism of fungal elicitor-induced secondary metabolite biosynthesis in medical plants.

Zhai X, Jia M, Chen L, Zheng CJ, Rahman K, Han T, Qin LP. Zhai X, et al. Crit Rev Microbiol. 2017 Mar;43(2):238-261. doi: 10.1080/1040841X.2016.1201041. Epub 2016 Dec 10. Crit Rev Microbiol. 2017. PMID: 27936989 Review.

10

2-Chloro-1-[4-(2-fluoro-benz-yl)piperazin-1-yl]ethanone.

Zhang C, Zhai X, Wan F, Gong P, Jiang Y. Zhang C, et al. Among authors: zhai x. Acta Crystallogr Sect E Struct Rep Online. 2011 Feb 26;67(Pt 3):o708. doi: 10.1107/S1600536811006180. Acta Crystallogr Sect E Struct Rep Online. 2011. PMID: 21522451 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

119 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year